In the MPTP mouse model for PD, adoptive i.v. transfer of Treg or in vivo Treg induction by treatment with recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) also protected nigral dopaminergic neurons - even without co-administration of mDAP. The gene discussed is CSF2; the disease is Parkinson disease.